alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Dettloff, Respondent, vs. Langkau, Appellant.

*February 5*

March *6, 1934.*

*369The cause was submitted for the appellant on the brief of *Lloyd D. Mitchell*of Oshkosh, and for the respondent on that of *Barber, Keefe, Patri & Hormts,*attorneys, and *Dan. M. Hildebrand*of counsel, all of Oshkosh.

Rosenberry, C. J.

We need not in this case be especially concerned about whether or not there existed between the plaintiff and Pasano the legal relation of .copartners. The question here is, Did the, adjustment and payment to Pasano by the defendant of the amount agreed upon discharge defendant’s liability under the contract? The great weight of the evidence preponderates clearly and convincingly in support of the defendant’s claim that Dettloff represented expressly and by acquiescence that he and Pasano were partners on this job. Such representation being made, Pasano had apparent authority, if not actual authority, to act in the matter and to receive payment.

The reason for the making of the representation has no bearing upon the question of whether or not it was made. If the plaintiff and Pasano were pretending to be partners to *370avoid the consequences of a violation of the rules of the Painters International, the defendant was not informed that it was a mere pretense or that the relation between them was other than that which they represented it to be. The trial court did not find that the representation was not made, but was apparently of the view that, unless a partnership in the full legal sense of that term existed, payment to Pasano did not discharge the defendant’s obligation. This for the reason stated was clearly error. There are other circumstances which support defendant’s contention. The first payments under the contract were made to Dettloff, who gave a receipt therefor. The defendant required Pasano to countersign these receipts. As a reasonable man he would not have done this unless he thought Pasano had an interest in the contract. While this does not appear to have been done with plaintiff’s knowledge, it strongly indicates the defendant’s understanding of the matter at a time when no dispute existed.

*By the Court.*— Judgment reversed, and cause remanded with directions to dismiss the plaintiff’s complaint.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED October 5, 2006 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-41835 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus JUAN CARLOS PEREZ-INFANTE, also known as Manuel Guzman-Ramirez, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas

USDC No. 7:05-CR-549

-------------------- Before JONES, Chief Judge, and SMITH and STEWART, Circuit Judges.
PER CURIAM: * Appealing the Judgment in a Criminal Case, Juan Carlos Perez-Infante raises arguments that are foreclosed by AlmendarezTorres v. United States , 523 U.S. 224, 235 (1998), which held that 8 U.S.C. § 1326(b)(2) is a penalty provision and not a separate criminal offense. The Government’s motion for summary affirmance is GRANTED, and the judgment of the district court is
AFFIRMED.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                          52,820                  20,454
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    7,390                   6,619
<ALLOWANCES>                                     1,998                   1,653
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                       4,551,123               4,280,773
<DEPRECIATION>                                 353,110                 267,051
<TOTAL-ASSETS>                               4,409,326               4,183,019
<CURRENT-LIABILITIES>                                0                       0
<BONDS>                                      2,071,169               1,975,317
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                       0
<OTHER-SE>                                           0                       0
<TOTAL-LIABILITY-AND-EQUITY>                 4,409,326               4,183,019
<SALES>                                              0                       0
<TOTAL-REVENUES>                               353,542                 309,381
<CGS>                                                0                       0
<TOTAL-COSTS>                                   98,867                  90,461
<OTHER-EXPENSES>                                75,395                  63,900
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              64,687                  58,710
<INCOME-PRETAX>                                114,593                  96,310
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            152,270                 106,141
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   132,755                  84,803
<EPS-BASIC>                                       1.79                    1.17
<EPS-DILUTED>                                     1.75                    1.16


</TABLE>
#### Elkins, Plaintiff in error, vs. The State, Defendant in error.

*November 9*

December *3, 1929.*

*271The cause was submitted for the plaintiff in error on the brief of Keller, *Keller & O’Leary*of Appleton, and for the defendant in error on that of the *Attorney General, J. B.*Messerschmidt, assistant attorney general, and *Frederick Aebischer*of Chilton.

Stevens, J.

The defendant does not contend that her roadhouse was not used for immoral purposes. Her defense is that she had no knowledge that the premises owned and occupied by her were being used for such purposes.

A careful examination of the entire record leaves no reasonable doubt in the minds of the members of this court that the defendant was the proprietor of a house of ill-fame and that she had full knowledge that her property was being used for that purpose by the inmates of the place.

*By the Court.*— Judgment affirmed.
# Materials Not Included in **Airworthiness Directive (AD) Docket**

Docket Number: FAA- 2007 -28661 Directorate Identifier: 2007NM013AD

CSB 233A3202 - 28 - 03 --- 1/12/06 AFM D631A001 (SEC 1, 3) --- 1/6/05

Name/Description of Item(s) Not Included in FDMS Docket and Maintained in the Supplemental AD Docket 

### MA **Y BE VIEWED AT:** Federal Aviation Adminis tration

Transport Airplane Directorate Rules Docket 1601 Lind Ave. SW., Renton, WA 98057 425.227.1221 **DURING THE HOURS OF:** 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays. Form Date: 03/05/2008
No. 90-751.

#### Karst *v.*Woods.

Ct. App. Cal., 1st App. Dist. Certiorari denied.
Exhibit 10.1


 


Tenzing Acquisition Corp


250 W 55th St, Suite 13D


New York, NY 10019


 


October 26, 2020


 


 


[Investor Name]

[Investor Address]

Attn: [_________________]


 


		Re:	Waiver of Deadline for Additional Shares under
Backstop Agreement



 


Dear [__________]:


 


Reference is hereby
made to that certain Backstop Agreement, dated as of October ___, 2020 (the “Backstop Agreement”), by
and among Tenzing Acquisition Corp., a company incorporated in the British Virgin Islands (together with its successors, the “Company”),
Reviva Pharmaceuticals, Inc., a Delaware corporation (together with its successors, “Reviva”), and [insert
Investor Name] (“Investor”). Any capitalized term used but not defined in this waiver letter (this “Waiver”)
will have the meaning ascribed to such term in the Backstop Agreement.


 


Under Section 4 of
the Backstop Agreement, Investor had until October 23, 2020 to purchase the applicable Backstop Shares in order to be eligible
to receive Additional Shares under the Backstop Agreement, but Investor failed to meet that deadline. Each of the Company and Reviva
hereby (i) waive Investor’s failure to meet the October 23, 2020 deadline to purchase the Backstop Shares under Section 4
of the Backstop Agreement and (ii) agree to extend the date by which Investor must purchase Backstop Shares in order to be eligible
to receive Additional Shares under Section 4 of the Backstop Agreement to November 13, 2020.


 


Except as expressly
amended hereby, the provisions of the Backstop Agreement remain in full force and effect, on the terms and subject to the conditions
set forth therein. This Waiver does not constitute, directly or by implication, an amendment or waiver of any provision of the
Backstop Agreement, or any other right, remedy, power or privilege of any party to the Backstop Agreement, except as expressly
set forth herein. The terms of this Waiver shall be governed by and construed in a manner consistent with the provisions of the
Backstop Agreement.


 


	 	Sincerely,
	 	 	 	 
	 	Tenzing Acquisition Corp.
	 	 	 	 
	 	 	 	 
	 	By:	 
	 	 	Name:	Rahul Nayar
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	Reviva Pharmaceuticals, Inc.
	 	 	 	 
	 	 	 	 
	 	By: 	 
	 	 	Name:	Laxminarayan Bhat
	 	 	Title:	Founder, President and CEO
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q/A

(Mark One)

|X|  Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934 
     For the quarterly period ended September 30, 1996.

                                       OR

|_|  Transition report pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934 
     For the Transition period ______________ to _____________.

                        Commission File Number: 0-21209

                           ADVANCED HEALTH CORPORATION
             (Exact name of registrant as specified in its charter)

            Delaware                                         13-3893841
(State or other jurisdiction of                            (IRS Employer
 incorporation or organization                          Identification No.)
                                 
                              555 White Plains Road
                            Tarrytown, New York 10591
          (Address of principal executive offices, including zip code)

                                 (914) 524-4200
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                                 Yes |_|     No |X|


As of November 18, 1996, there were 7,145,267 shares outstanding of the
registrant's Common Stock, $.01 par value.

================================================================================

<PAGE>

                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


November 19, 1996                  ADVANCED HEALTH CORPORATION



                              By:  /s/ Jonathan Edelson
                                   ---------------------------
                                   Jonathan Edelson, M.D.
                                   Chairman of the Board and
                                   Chief Executive Officer
                                   (Principal Executive Officer)


                              By:  /s/ Alan B. Masarek
                                   ---------------------------
                                   Alan B. Masarek
                                   Chief Operating Officer and
                                   Chief Financial Officer
                                   (Principal Financial and Accounting Officer)


                                       (2)
#### State, Plaintiff in error, vs. Warnimont and others, Defendants in error.

*April 3*

April *28, 1936.*

For the plaintiff in error there was a brief by the *Attorney General, J. E. Messerschmidt,*assistant attorney general, *William A. Zabel,*district attorney of Milwaukee county, *Herman A. Mosher,*deputy district attorney, and *Francis A. Darnieder,*special assistant district attorney, and oral argument by *Mr. Darnieder*and *Mr. Mosher.*

*Walter H. Bender*and *George A. Burns,*both of Milwaukee, for the defendants in error Eugene Warnimont, Joseph Schoendorf, Leo Stein, F. N. Lochemes, Frank DeYoung, and Jordan Schuster.

Per Curiam.

This case was argued and submitted with the case of *State v. Kitzerow, ante,*p. 436, 267 N. W. 71, and is ruled by the decision in that case.

The order of the circuit court is affirmed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# AGENCY:

                        Postal ServiceTM.                    

# ACTION:

Notice.

# SUMMARY:

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

# DATES:

*Date of required notice:*                         November 29, 2024.                    

# FOR FURTHER INFORMATION CONTACT:

Sean Robinson, 202-268-8405.

# SUPPLEMENTARY INFORMATION:

                    The United States Postal Service® hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on November 19, 2024, it filed with the Postal Regulatory Commission a                     *USPS Request to Add Priority Mail & USPS Ground Advantage® Contract 472 to Competitive Product List.*                     Documents are available at                     *www.prc.gov,*                     Docket Nos. MC2025-457, K2025-454.                

Sean Robinson,

Attorney, Corporate and Postal Business Law.

[FR Doc. 2024-27931 Filed 11-27-24; 8:45 am]

BILLING CODE 7710-12-P
Exhibit 32



   CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER OF
                            HORIZON FINANCIAL CORP.
         PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
Section 1350), each of the undersigned hereby certifies in his capacity as an
officer of Horizon Financial Corp. (the "Company") and in connection with this
Quarterly Report on Form 10-Q ("Report"), that:

     1.   the report fully complies with the requirements of Sections 13(a)
          and 15(d) of the Securities Exchange Act of 1934, as amended, and

     2.   the information contained in the report fairly presents, in all
          material respects, the Company's financial condition and results of
          operations, as of the dates and for the periods presented in the
          financial statements included in the Report.


/s/ Richard P. Jacobson             /s/ Greg B. Spear
------------------------------      ---------------------------------
Richard P. Jacobson                 Greg B. Spear
Chief Executive Officer             Chief Financial Officer


Dated:  February 6, 2009



<PAGE>
No. 91-6137.

#### Nave *v.*Delaware.

C. A. 3d Cir. Certiorari denied.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          21,042
<SECURITIES>                                         0
<RECEIVABLES>                                    9,158
<ALLOWANCES>                                       301
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       3,570,822
<DEPRECIATION>                                 183,639
<TOTAL-ASSETS>                               3,780,131
<CURRENT-LIABILITIES>                                0
<BONDS>                                      1,847,854
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 3,780,131
<SALES>                                              0
<TOTAL-REVENUES>                               125,307
<CGS>                                                0
<TOTAL-COSTS>                                   33,689
<OTHER-EXPENSES>                                24,408
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              29,267
<INCOME-PRETAX>                                 37,943
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             37,943
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    45,703
<EPS-PRIMARY>                                     0.66
<EPS-DILUTED>                                     0.65
        

</TABLE>
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1496 Referred in Senate (RFS)]

<DOC>
115th CONGRESS
  2d Session
                                H. R. 1496

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2018

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
    at 3585 South Vermont Avenue in Los Angeles, California, as the 
                      ``Marvin Gaye Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MARVIN GAYE POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located at 3585 South Vermont Avenue in Los Angeles, California, shall 
be known and designated as the ``Marvin Gaye Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Marvin 
Gaye Post Office''.

            Passed the House of Representatives May 7, 2018.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. 1350 (as adopted pursuant to 906 of the Sarbanes-
Oxley Act of 2002), I, the Chief Executive Officer of Casino Journal
Publishing Group, Inc. (the 'Company"), hereby certify, that to the
best of my knowledge, the Quarterly report on Form 10-QSB of the
Company for the quarterly period ended June 30, 2003 (the "Report")
fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in the
Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

Date: August 14, 2003

/s/Glenn Fine
-------------------------------------
Glenn Fine,
Chairman and Chief Executive Officer




CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. 1350 (as adopted pursuant to 906 of the Sarbanes-
Oxley Act of 2002), I, the Chief Financial Officer of Casino Journal
Publishing Group, Inc. (the "Company"), hereby certify, that to the
best of my knowledge, the Quarterly report on Form 10-QSB of the
Company for the quarterly period ended June 30, 2003 (the "Report")
fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in the
Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

Date: August 14, 2003

 /s/ Derek James
-----------------------------
Derek James, Chief Financial Officer